Related Experiment Video
Updated: Jul 25, 2025
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Radiogenomics in NF2-Associated Schwannomatosis (Neurofibromatosis Type II): Exploratory Data Analysis
Gleb Danilov1, Elizaveta Makashova2, Mikhail Galkin2
1Laboratory of Biomedical Informatics and Artificial Intelligence, National Medical Research Center for Neurosurgery named after N.N. Burdenko, Moscow, Russian Federation.
This pilot study explored radiogenomic analysis in NF2-associated schwannomatosis, identifying imaging patterns and radiomic features linked to disease characteristics. Further evaluation is needed to confirm clinical utility.
Area of Science:
- Radiology
- Oncology
- Genetics
Background:
- Schwannomatosis, particularly NF2-associated, presents complex challenges in diagnosis and treatment.
- Identifying reliable biomarkers for schwannomatosis is crucial for personalized medicine.
Purpose of the Study:
- To conduct exploratory radiogenomic data analysis in patients with NF2-associated schwannomatosis.
- To assess the potential of imaging biomarkers for this pathology.
Main Methods:
- Analysis of 3718 radiomic features (first-order, GLCM, GLRLM, geometry-based) from 53 patients.
- Exploratory data analysis to identify imaging patterns and feature differences.
Main Results:
- Demonstrated distinct imaging patterns in NF2-associated schwannomatosis.
- Identified statistically significant differences in radiomic features potentially related to genotype and clinical phenotype.
Conclusions:
- Radiogenomic analysis shows promise for identifying imaging biomarkers in schwannomatosis.
- Further research is required to validate the clinical utility of these radiomic patterns.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024